Related Experiment Video
Updated: Jun 28, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
High vs low CPAP strategy with aerosolized calfactant in preterm infants with respiratory distress syndrome
D C Kaluarachchi1, E Gerday2, T Bahr2
1Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, USA. kaluarachchi@pediatrics.wisc.edu.
Insights
High versus low continuous positive airway pressure (CPAP) strategies did not differ in preventing CPAP failure in infants receiving aerosolized calfactant. Further research is needed to confirm these findings.
Area of Science:
- Neonatal respiratory support
- Pulmonary surfactant therapy
Background:
- Continuous positive airway pressure (CPAP) is a common respiratory support method for preterm infants.
- The optimal CPAP strategy to prevent CPAP failure, defined as the need for endotracheal intubation, remains unclear.
- Aerosolized calfactant is a potential therapeutic agent for respiratory distress syndrome.
Purpose of the Study:
- To compare the risk of CPAP failure between high and low CPAP strategies in infants receiving aerosolized calfactant.
- To analyze data from the AERO-02 clinical trial and AERO-03 expanded access program.
Main Methods:
- Infants born between 29 0/7 and 36 6/7 weeks of gestation were included.
- Infants were assigned to either a low CPAP group (4-7 cm H2O) or a high CPAP group (8-10 cm H2O).
- CPAP failure and pneumothorax rates were compared between the groups.
Main Results:
- There were no significant differences in CPAP failure or pneumothorax rates between the high and low CPAP groups.
- The adjusted odds ratio for CPAP failure was 0.61 (95% CI: 0.29, 1.24), indicating no statistically significant difference.
- Baseline characteristics did not significantly alter the observed outcomes.
Conclusions:
- The study found no difference in CPAP failure rates when comparing high versus low CPAP strategies in infants receiving aerosolized calfactant.
- The efficacy of a high CPAP strategy in conjunction with aerosolized surfactant treatment requires further investigation in future studies.
Background:
Optimal CPAP strategy to prevent CPAP failure defined as need for endotracheal intubation is unknown.
Objective:
To evaluate the risk of CPAP failure in infants treated with high vs low CPAP strategy while receiving aerosolized calfactant in the AERO-02 clinical trial and AERO-03 expanded access program.
Methods:
Infants born between 29 0/7 to 36 6/7 weeks were included. Comparisons were made between low and high CPAP groups (Low, 4-7 cm H2O; High, 8-10 cm H2O).
Results:
CPAP failure and pneumothorax were not different between the groups. Odds of CPAP failure were not different after adjustment for baseline characteristics (OR = 0.61; 95% CI: 0.29, 1.24).
Conclusion:
We found no difference in CPAP failure among infants who received aerosolized calfactant that were treated with high vs low CPAP strategy. Efficacy of high CPAP strategy with aerosolized surfactant treatment needs to be evaluated in future studies.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Breathing
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Acute Respiratory Failure-III
Inhaled Medications

